Hyperfine, Inc. (HYPR)
0.8144
+0.02
(+2.32%)
USD |
NASDAQ |
Sep 25, 16:00
0.8144
0.00 (0.00%)
After-Hours: 19:44
Hyperfine Cash from Operations (TTM) : -27.06M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -27.06M |
| March 31, 2026 | -27.71M |
| December 31, 2025 | -27.95M |
| September 30, 2025 | -31.10M |
| June 30, 2025 | -34.03M |
| March 31, 2025 | -35.51M |
| December 31, 2024 | -38.77M |
| September 30, 2024 | -40.35M |
| June 30, 2024 | -40.55M |
| March 31, 2024 | -40.83M |
| Date | Value |
|---|---|
| December 31, 2023 | -41.81M |
| September 30, 2023 | -47.22M |
| June 30, 2023 | -51.29M |
| March 31, 2023 | -58.54M |
| December 31, 2022 | -72.34M |
| September 30, 2022 | -75.13M |
| June 30, 2022 | -72.28M |
| March 31, 2022 | -66.98M |
| December 31, 2021 | -47.18M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Abbott Laboratories | 9.905B |
| AngioDynamics, Inc. | 3.089M |
| Alphatec Holdings, Inc. | 56.52M |
| AtriCure, Inc. | 64.94M |
| Baxter International, Inc. | 1.319B |